IceCure Medical (ICCM) Enterprise Value (2020 - 2026)

IceCure Medical (ICCM) has 7 years of Enterprise Value data on file, last reported at -$8.1 million in Q1 2026.

• Quarterly Enterprise Value fell 34.35% year-over-year to -$8.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.1 million (down 34.35% YoY) and the FY2025 annual result came in at -$8.9 million, down 17.62% from the prior year.
• Enterprise Value advanced to -$8.1 million in Q1 2026 per ICCM's latest filing, from -$8.9 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$6.0 million in Q1 2025 and bottomed at -$24.0 million in Q4 2022.
• The 5-year median for Enterprise Value is -$8.5 million (2025), against an average of -$10.9 million.
• The widest annual swing landed in 2023, when Enterprise Value jumped 53.82%; it then tumbled 34.35% in 2026.
• Tracing ICCM's Enterprise Value over 5 years: stood at -$24.0 million in 2022, then jumped by 53.82% to -$11.1 million in 2023, then soared by 31.62% to -$7.6 million in 2024, then retreated by 17.62% to -$8.9 million in 2025, then rose by 8.79% to -$8.1 million in 2026.
• Per Business Quant, the three latest ICCM Enterprise Value figures stand at -$8.1 million (Q1 2026), -$8.9 million (Q4 2025), and -$6.0 million (Q1 2025).

Peer Comparison